STRATA Skin Sciences, Inc.
SSKN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $111 | $192 | $274 | $499 |
| - Cash | $7 | $7 | $5 | $13 |
| + Debt | $16 | $16 | $8 | $8 |
| Enterprise Value | $120 | $201 | $277 | $494 |
| Revenue | $34 | $33 | $36 | $30 |
| % Growth | 0.6% | -7.8% | 20.6% | – |
| Gross Profit | $19 | $18 | $22 | $20 |
| % Margin | 56.9% | 55.3% | 60.2% | 66.2% |
| EBITDA | -$3 | -$3 | $1 | $2 |
| % Margin | -8.5% | -10.1% | 3.1% | 5.8% |
| Net Income | -$10 | -$11 | -$6 | -$3 |
| % Margin | -30.1% | -32.5% | -15.3% | -9% |
| EPS Diluted | -0.26 | -0.31 | -0.16 | -0.08 |
| % Growth | 16.1% | -93.8% | -101.3% | – |
| Operating Cash Flow | $0 | -$1 | -$1 | $2 |
| Capital Expenditures | -$2 | -$5 | -$4 | -$4 |
| Free Cash Flow | -$1 | -$6 | -$5 | -$2 |